RELMADA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.83 USD | +3.51% |
|
-4.25% | -7.49% |
| 03-19 | Transcript : Relmada Therapeutics, Inc., 2023 Earnings Call, Mar 19, 2024 | |
| 03-19 | Relmada Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 4.680 | 6.800 | 6.800 |
| Spread/Res. | -18.16% | -43.68% | -43.68% |
| Spread/Supp. | +3.51% | +56.33% | +55.69% |
| Support | 3.700 | 2.450 | 2.460 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- RLMD Stock
- Charts Relmada Therapeutics, Inc.
